SARS-CoV-2 RNA vaccine compositions and methods of use
US12257299B2 · kind B2 · utility
0Cited by
22References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2024 |
| Grant date | Mar 25, 2025 |
| Priority date | — |
| Expiry date | Mar 21, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/36143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides compositions, methods of treatment, and methods of making and using compositions to deliver a nucleic acid to a subject. Methods of using the compositions as a COVID-19 vaccine for the treatment of a coronavirus infection are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.